Prevention of Primary Vascular Graft Infection with Silver-Coated Polyester Graft in a Porcine Model

Mussa, 2007, Prevention and treatment of aortic graft infection, Expert Rev Anti Infect Ther, 5, 305, 10.1586/14787210.5.2.305 O'Brien, 1992, Prosthetic vascular graft infection, Br J Surg, 79, 1262, 10.1002/bjs.1800791205 Edwards, 1987, Primary graft infections, J Vasc Surg, 6, 235, 10.1016/0741-5214(87)90034-6 Seeger, 2000, Management of patients with prosthetic vascular graft infection, Am Surg, 66, 166, 10.1177/000313480006600213 Perera, 2006, Aortic graft infection: update on management and treatment options, Vasc Endovascular Surg, 40, 1, 10.1177/153857440604000101 Kalteis, 2006, Treatment of implant-associated infections with moxifloxacin: an animal study, Int J Antimicrob Agents, 27, 444, 10.1016/j.ijantimicag.2005.12.003 Hernandez-Richter, 2000, The prevention and treatment of vascular graft infection with a Triclosan (Irgasan)-bonded Dacron graft: an experimental study in the pig, Eur J Vasc Endovasc Surg, 20, 413, 10.1053/ejvs.2000.1199 Schierholz, 1998, Efficacy of silver-coated medical devices, J Hosp Infect, 40, 257, 10.1016/S0195-6701(98)90301-2 Darouiche, 1999, Anti-infective efficacy of silver-coated medical prostheses, Clin Infect Dis, 29, 1371, 10.1086/313561 McDonnell, 1999, Antiseptics and disinfectants: activity, action, and resistance, Clin Microbiol Rev, 12, 147, 10.1128/CMR.12.1.147 Hernandez-Richter, 2003, Rifampin and Triclosan but not silver is effective in preventing bacterial infection of vascular dacron graft material, Eur J Vasc Endovasc Surg, 26, 550, 10.1016/S1078-5884(03)00344-7 Hardman, 2004, An in vitro model to compare the antimicrobial activity of silver-coated versus rifampicin-soaked vascular grafts, Ann Vasc Surg, 18, 308, 10.1007/s10016-004-0042-5 Ueberrueck, 2005, Vascular graft infections: in vitro and in vivo investigations of a new vascular graft with long-term protection, J Biomed Mater Res B Appl Biomater, 74, 601, 10.1002/jbm.b.30265 Goeau-Brissonniere, 2002, Comparison of the resistance to infection of rifampicin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses, J Vasc Surg, 35, 1260, 10.1016/S0741-5214(02)67047-8 Schmacht, 2005, Graft infectivity of rifampicin and silver-bonded polyester grafts to MRSA contamination, Vasc Endovascular Surg, 39, 411, 10.1177/153857440503900505 Williams, 1988, Albumin adsorption on metal surfaces, Biomaterials, 9, 206, 10.1016/0142-9612(88)90085-3 Shah, 1987, PTFE graft treated with silver norfloxacin (AgNF): drug retention and resistance to bacterial challenge, J Surg Res, 42, 298, 10.1016/0022-4804(87)90147-8 Benvenisty, 1988, Control of prosthetic bacterial infection: evaluation of an easily incorporated, tightly bound, silver antibiotic PTFE graft, J Surg Res, 44, 1, 10.1016/0022-4804(88)90116-3 Kinney, 1991, Antibiotic-bonded PTFE vascular grafts: the effect of silver antibiotic on bioactivity following implantation, J Surg Res, 50, 430, 10.1016/0022-4804(91)90020-M Bandyk, 2001, Use of rifampicin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections, J Surg Res, 95, 44, 10.1006/jsre.2000.6035 Atahan, 2007, Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model, Eur J Vasc Endovasc Surg, 34, 182, 10.1016/j.ejvs.2007.03.002 Lehnhardt, 2002, Systemic and local antibiotic prophylaxis in the prevention of prosthetic vascular graft infection: an experimental study, Eur J Vasc Endovasc Surg, 23, 127, 10.1053/ejvs.2001.1571 Koshiko, 2002, Limitations in the use of rifampicin-gelatin grafts against virulent organisms, J Vasc Surg, 35, 779, 10.1067/mva.2002.121850 Javerliat, 2007, Prevention of Staphylococcus aureus graft infection by a new gelatin-sealed vascular graft prebonded with antibiotics, J Vasc Surg, 46, 1026, 10.1016/j.jvs.2007.06.023